G0533
HCPCSBuprenorphone inj weekly
Official HCPCS Level II long descriptor
Medication assisted treatment, buprenorphine (injectable) administered on a weekly basis; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)
HCPCS Level II code G0533 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Buprenorphone inj weekly
Added to HCPCS: 2025-01-01
Nearby codes in G0
- G0525Est pt-cg dyad dem mod cmplx
- G0526Est pt-cg dyad dem hig cmplx
- G0527Mgt est pt dmentia low cmplx
- G0528Mgt est pt dem mod-hi cmplx
- G0529In home respite care, 4 hr u
- G0530Adult daycare center, 8 hr u
- G0531Fclty-based respite, 24 hr u
- G0532Take home supp nasal spray
- G0534Coordinated care/or referral
- G0535Pt navigat svs direct/ref
- G0536Peer recover support svs
- G0537Risk ascvd tst once pr 12 mo
- G0538Ascvd rsk mng clin stf pr mo
- G0539Initial care training 30 m
- G0540Train for caregiver add 15
- G0541No pt prsnt train initial 30
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.